Restricted accessResearch articleFirst published online 2011-4
The relative contribution of viral and bacterial sexually transmitted infections on HIV acquisition in southern African women in the Methods for Improving Reproductive Health in Africa study
We assess the relative contribution of viral and bacterial sexually transmitted infections (STIs) on HIV acquisition among southern African women in a nested case-control study within the Methods for Improving Reproductive Health in Africa (MIRA) trial. Cases were women with incident HIV infection; controls were HIV-uninfected at the time of case seroconversion selected in a 1 to 3 case to control ratio (risk-set sampling), matched on study site and time of follow-up. Conditional logistic regression models were used to calculate adjusted odds ratios (AORs) and population-attributable fractions (PAF). Among 4948 enrolled women, we analysed 309 cases and 927 controls. The overall HIV incidence rate was 4.0 per 100 women-years. The incidence of HIV infection was markedly higher in women who had prevalent Herpes simplex virus type 2 (HSV-2) (AOR: 2.14; 95% confidence interval [CI]: 1.55–2.96), incident HSV-2 (AOR: 4.43; 95% CI: 1.77–11.05) and incident Neisseria gonorrhoeae (AOR: 6.92; 95% CI: 3.01–15.90). The adjusted PAF of HIV incidence for prevalent HSV-2 was 29.0% (95% CI: 16.8–39.3), for incident HSV-2 2.1% (95% CI: 0.6–3.6) and for incident N. gonorrhoeae 4.1% (95% CI: 2.5–5.8). Women's greatest risk factors for HIV acquisition were incident bacterial and viral STIs. Women-centred interventions aimed at decreasing HIV incidence in young African women need to address these common co-morbid conditions.
UNAIDS. UNAIDS/WHO AIDS epidemic update. 2007. See http://www.unaids.org/epidemic-update/ (last checked 9 May 2008)
2.
Human Sciences Research Council. South African National HIV Prevalence, Incidence, Behavior, and Communication Survey, 2008: A Turning Tide Among Teenagers?Cape Town, South Africa: HSRC Press, 2008
3.
BertozziS, LagaM, Bautista-ArredondoS, CoutinhoA. Making HIV prevention programmes work. Lancet2008;372:831–44
FoxJ, FidlerS. Sexual transmission of HIV-1. Antiviral Res2010;85:276–85
6.
DosekunO, FoxJ. An overview of the relative risks of different sexual behaviours on HIV transmission. Curr Opin HIV AIDS2010;5:291–7
7.
ToddJ, GrosskurthH, ChangaluchaJ, Risk factors influencing HIV infection incidence in a rural African population: a nested case-control study. J Infect Dis2006;193:458–66
8.
GrosskurthH, MoshaF, ToddJ, Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet1995;346:530–6
9.
WawerM, SewankamboNK, SerwaddaD, Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group. Lancet1999;353:525–35
10.
LagaMMA, KivuvuM, MaleleB, Non-ulcerative secually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS1993;7:95–102
11.
DallabettaG, NeilsonG. Efforts to control sexually transmitted infections as a means to limit HIV transmission: what is the evidence?Curr Infect Dis Rep2004;7:79–84
12.
HalperinD, EpsteinH. Concurrent sexual partnerships help to explain Africa's high HIV prevalence: implications for prevention. Lancet2004;364:4–6
13.
RøttingenJ, CameronDW, GarnettGP. A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known?Sex Transm Dis2001;28:579–97
14.
FlemingD, WasserheitJN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect1999;75:3–17
15.
GrosskurthH, GrayR, HayesR, MabeyD, WawerM. Control of sexually transmitted diseases for HIV-1 prevention: understanding the implications of the Mwanza and Rakai trials. Lancet2000;355:1981–7
16.
CoreyL, WaldA, CelumCL, QuinnTC. The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J Acquir Immun Defic Syndr2004;35:435–45
17.
FreemanE, WeissHA, GlynnJR, CrossPL, WhitworthJA, HayesRJ. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS2006;20:73–83
18.
GlynnJ, BiraroS, WeissHA. Herpes simplex virus type 2: a key role in HIV incidence. AIDS2009;23:1595–8
19.
KaulR, KimaniJ, NagelkerkeNJ, Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers: a randomized controlled trial. J Am Med Assoc2004;291:2555–62
20.
ZetolaN, BernsteinKT, WongE, LouieB, KlausnerJD. Exploring the relationship between sexually transmitted diseases and HIV acquisition by using different study designs. J Acquir Immun Defic Syndr2009;50:546–51
21.
PadianN, van der StratenA, RamjeeG, Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet2007;370:251–61
22.
Van Der PolB, KwokC, Pierre-LouisB, Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. J Infect Dis2008;197:548–54
23.
QuigleyM, MorganA, MalambaSS, Case-control study of risk factors for incident HIV infection in rural Uganda. J Acquir Immun Defic Syndr2000;23:418–25
24.
SerwaddaD, GrayRH, SewankamboNK, Human immunodeficiency virus acquisition associated with genital ulcer disease and herpes simplex virus type 2 infection: a nested case-control study in Rakai, Uganda. J Infect Dis2003;188:1492–7
25.
OrrorthK, GavyoleA, ToddJ, Syndromic treatment of sexually transmitted diseases reduces the proportion of incident HIV infections attributable to these diseases in rural Tanzania. AIDS2000;14:1429–37
26.
RothmanK, GreenlandS, LashTL. Modern Epidemiology. 3rd edn.Philadelphia: Walters Kluwer, 2008
27.
GreenlandS, ThomasDC, MorgensternH. The rare-disease assumption revisited. A critique of “estimators of relative risk for case-control studies”. Am J Epidemiol1986;124:869–83
28.
BoeraT, WeirSS. Integrating demographic and epidemiological approaches to research on HIV/AIDS: the proximate-determinants framework. J Infect Dis2005;191(Suppl 1):S61–7
29.
LewisJ, DonnellyCA, MareP, MupambireyiZ, GarnettGP, GregsonS. Evaluating the proximate determinants framework for HIV infection in rural Zimbabwe. Sex Transm Infect2007;83(Suppl 1):i61–9
30.
GreenlandS, RobinsJM. Conceptual problems in the definition and interpretation of attributable fractions. Am J Epidemiol1988;128:1185–97
31.
GreenlandS, DrescherK. Maximum likelihood estimation of the attributable fraction from logistic models. Biometrics1993;49:865–72
32.
SzkloM, NietoFJ. Epidemiology Beyond the Basics. 2nd edn.Sudbury, MA: Jones and Bartlett Publishers, 2006
33.
del Mar Pujades RodríguezM, ObasiA, MoshaF, Herpes simplex virus type 2 infection increases HIV incidence: a prospective study in rural Tanzania. AIDS2002;16:451–62
34.
BaetenJ, BenkiS, ChohanV, Hormonal contraception use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women. AIDS2007;21:1771–7
35.
BrownJ, WaldA, HubbardA, Incident and prevalent herpes simplex virus type 2 infection increases risk of HIV acquisition among women in Uganda and Zimbabwe. AIDS2007;21:1515–23
36.
ZhuJ, HladikF, WoodwardA, Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition. Nat Med2009;15:886–92
37.
MoriuchiM, MoriuchiH, WilliamsR, StrausSE. Herpes simplex virus infection induces replication of human immunodeficiency virus type 1. Virology2000;278:534–40
38.
BenedettiJ, ZehJ, CoreyL. Clinical reactivation of genital herpes simplex virus infection decreases in frequency over time. Ann Intern Med1999;131:14–20
39.
Watson-JonesD, WeissHA, RusizokaM, Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med2008;358:1560–71
40.
CelumC, WaldA, HughesJ, Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. Lancet2008;371:2109–19
41.
KorenrompE, WhiteRG, OrrothKK, Determinants of the impact of sexually transmitted infection treatment on prevention of HIV infection: a synthesis of evidence from the Mwanza, Rakai, and Masaka intervention trials. J Infect Dis2005;191:S168–78
42.
GrayR, WawerMJ, BrookmeyerR, Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet2001;357:1149–53
43.
CohenM, HoffmanIF, RoyceRA, Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet1997;349:1868–73
44.
SextonJ, GarnettG, RøttingenJA. Metaanalysis and metaregression in interpreting study variability in the impact of sexually transmitted diseases on susceptibility to HIV infection. Sex Transm Dis2005;32:351–7
45.
Napierala MavedzengeS, Van Der PolB, ChengH, Epidemiological synergy of Trichomonas vaginalis and HIV in Zimbabwean and South African women. Sex Transm Dis2010;37:460–66
46.
RosenblumM, JewellNP, van der LaanM, ShiboskiS, van der StratenA, PadianA. Analyzing direct effects in randomized trials with secondary interventions: an application to human immunodeficiency virus prevention trials. J Roy Stat Soc2009;172(Part 2):443–65
